Strom Law Firm Columbia SC
No obligations & no credit card required

Takeda Pharmaceuticals Wins Nevada Actos Lawsuit

Pharmaceutical Company Wins Actos Lawsuit in Nevada

Over the past couple of years a number of Actos lawsuits have been filed. The Japanese pharmaceutical manufacturer behind Actos was recently found not liable in a massive personal injury case in Nevada, in which two plaintiffs alleged that the Type 2 diabetes drug caused bladder cancer.

The lawsuit was heard in Las Vegas, Nevada. On May 22nd, a jury decided that Actos was not responsible for the bladder cancer suffered by the two plaintiffs in the personal injury lawsuit.

“We’re very pleased we prevailed,” Takeda’s general counsel, Kenneth Greisman, said in a phone interview. “We remain confident Actos is an important treatment for patients.”

“It was obviously disappointing — particularly disappointing for the clients, because that is why we do this,” said the attorney for one of the plaintiffs, Robert Eglet.

The two plaintiffs – Bertha Triana and Delores Cipriano – asked for the largest possible sum available in Las Vegas personal injury claims, which is $1 billion.

Both Triana and Cipriano were diagnosed with bladder cancer after the two had been prescribed Actos to treat their Type 2 diabetes for years.

Eglet said that he has two other plaintiffs who allege that Takeda Pharmaceuticals caused their bladder cancer injuries. That Actos trial will move forward in October of this year.

“The question is: Would they have developed the bladder cancer anyway without Actos?”  said Adam Levine, a Florida-based doctor and lawyer.

“Justice really hasn’t been served for anybody, because the verdict is still out about whether Actos causes cancer,” Levine said.

“Takeda is confident in the therapeutic benefits of ACTOS and its importance as a treatment for type 2 diabetes and we will continue to defend the company vigorously in these cases,” Senior Vice President and general counsel Kenneth D. Greisman said.

Actos Linked to Serious Personal Injury

The FDA is currently investigating the risks of taking Actos, and says their review will wrap up next year. Based on evidence from new studies, the government agency issued a warning against Actos and said Takeda had to package their drug with the strongest possible warning label. Meanwhile, both France and Germany banned the drug from sale in their countries, and most recently, India temporarily banned

Actos and the generic form pioglitazone, but after confrontations with doctors, rescinded the ban pending further study. The generic form of Actos, pioglitazone, was approved for use by the FDA last August.

There are several side effects associated with Actos.  You should seek medical attention if you experience:

•       shortness of breath or trouble breathing,

•       chest pain,

•       extreme fatigue,

•       irregular heartbeat,

•       dilated neck veins,

•       swelling of face, fingers, feet, or lower legs,

•       decreased urine output, and

•       weight gain

The Strom Law Firm Can Help with Personal Injury and Wrongful Death Cases, Including Against Actos

If you or a loved one have taken Actos to treat Type 2 diabetes, and have since suffered dangerous side effects including developing bladder cancer, heart disease, liver failure, or diabetic macular edema, you may be entitled to compensation. The attorneys at the Strom Law Firm can help with personal injury cases, including against Actos manufacturer Takeda Pharmaceuticals. We offer free, confidential consultations to discuss the facts of your case, so do not hesitate to contact us803.252.4800

Share:

Facebook
Twitter
LinkedIn
Categories
Archives

Follow us

Sign Up For Our Newsletter!